| ［1］ |
Ringrose L, Paro R. Epigenetic regulation of cellular memory by the polycomb and trithorax group proteins［J］. Annu Rev Genet, 2004,38:413⁃443. doi: 10.1146/annurev.genet.38.072902. 091907.
|
| ［2］ |
Levine SS, Weiss A, Erdjument⁃Bromage H, et al. The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans［J］. Mol Cell Biol, 2002,22（17）:6070⁃6078. doi: 10.1128/mcb.22.17.6070⁃6078. 2002.
|
| ［3］ |
Visser HP, Gunster MJ, Kluin⁃Nelemans HC, et al. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma［J］. Br J Haematol, 2001,112（4）:950⁃958. doi: 10.1046/j.1365⁃2141.2001.02641.x.
|
| ［4］ |
Han L, Zhang HC, Li L, et al. Downregulation of long noncoding RNA HOTAIR and EZH2 induces apoptosis and inhibits proliferation, invasion, and migration of human breast cancer cells［J］. Cancer Biother Radiopharm, 2018,33（6）:241⁃251. doi: 10.1089/cbr.2017.2432.
|
| ［5］ |
Chen Z, Yang P, Li W, et al. Expression of EZH2 is associated with poor outcome in colorectal cancer［J］. Oncol Lett, 2018,15（3）:2953⁃2961. doi: 10.3892/ol.2017.7647.
|
| ［6］ |
陈实, 陈江枝. Ring1A/B在基因表达过程中的表观调控作用［J］. 创伤与急诊电子杂志, 2017,5（1）:31⁃34. doi: 10.16746/j.cnki.11⁃9332/r.2017.01.010.
|
| ［7］ |
Daures M, Idrissou M, Judes G, et al. A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2［J］. Oncotarget, 2018,9（34）:23413⁃23425. doi: 10.18632/oncotarget. 25182.
|
| ［8］ |
Shi M, Shahsafaei A, Liu C, et al. Enhancer of zeste homolog 2 is widely expressed in T⁃cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases［J］. Leuk Lymphoma, 2015,56（7）:2087⁃2091. doi: 10.3109/10428194.2014.968780.
|
| ［9］ |
林璐慧. 组蛋白甲基转移酶EZH2在血液肿瘤中表观遗传调控作用的研究进展［J］. 白血病·淋巴瘤, 2014,23（3）:185⁃188. doi: 10.3760/cma.j.issn.1009⁃9921.2014.03.019.
|
| ［10］ |
Kirmizis A, Bartley SM, Farnham PJ. Identification of the polycomb group protein SU（Z）12 as a potential molecular target for human cancer therapy［J］. Mol Cancer Ther, 2003,2（1）:113⁃121.
|
| ［11］ |
Liu Q, Wang G, Li Q, et al. Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer［J］. Int J Cancer, 2019,145（2）:415⁃426. doi: 10.1002/ijc.32118.
|
| ［12］ |
Ntziachristos P, Tsirigos A, Van Vlierberghe P, et al. Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia［J］. Nat Med, 2012,18（2）:298⁃301. doi: 10.1038/nm.2651.
|
| ［13］ |
吴贝, 李志英, 王俊杰. DZNep在肿瘤治疗中的研究进展［J］. 肿瘤, 2016,36（8）:938⁃943. doi: 10.3781/j.issn.1000⁃7431.2016. 55.149.
|
| ［14］ |
Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life［J］. Nature, 2011,469（7330）:343⁃349. doi: 10.1038/nature09784.
|
| ［15］ |
杨斌, 陈瑞平, 杨雷, 等. EZH1/2在心血管发育及其疾病中的研究进展［J］. 转化医学电子杂志, 2018,5（6）:9⁃15. doi: 10. 12095/j.issn.2095⁃6894.2018.06.002.
|
| ［16］ |
Calebiro D, Grassi ES, Eszlinger M, et al. Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas［J］. J Clin Invest, 2016,126（9）:3383⁃3388. doi: 10.1172/JCI84894.
|
| ［17］ |
Vo LT, Kinney MA, Liu X, et al. Regulation of embryonic haematopoietic multipotency by EZH1［J］. Nature, 2018,553（7689）:506⁃510. doi: 10.1038/nature25435.
|
| ［18］ |
Hidalgo I, Gonzalez S. New epigenetic pathway for stemness maintenance mediated by the histone methyltransferase Ezh1［J］. Cell Cycle, 2013,12（3）:383⁃384. doi: 10.4161/cc.23550.
|
| ［19］ |
Abdalkader L, Oka T, Takata K, et al. Aberrant differential expression of EZH1 and EZH2 in polycomb repressive complex 2 among B⁃ and T/NK⁃cell neoplasms［J］. Pathology, 2016,48（5）:467⁃482. doi: 10.1016/j.pathol.2016.05.002.
|
| ［20］ |
Nayak V, Xu C, Min J. Composition, recruitment and regulation of the PRC2 complex［J］. Nucleus, 2011,2（4）:277⁃282. doi: 10. 4161/nucl.2.4.16266.
|
